GSK will shut down U.S. consumer factories and cut 260 jobs!

GSK has announced that it will close its OTC manufacturing plant in Carlisle, Pennsylvania, in 2021, affecting about 260 employees In response to local media pennlive on February 18, GSK pointed out that "after careful review, GSK decided to close the Carlisle plant and move this part of production to the plant in guashan City, Puerto Rico, in order to consolidate production and improve efficiency GSK said that by the middle of 2021, Carlisle plant will gradually end production, and will withdraw completely by the end of 2021 The closure of the plant appears to coincide with the expiration of its 10-year lease It is reported that the production line of Carlisle plant was started in 2011 At present, it is mainly operated by GSK to produce emergen-c, a powder beverage mixed with vitamin C supplements Emergen-c supplement produced by GSK Carlisle factory was originally manufactured by Alacer Corp Alacer was acquired by Pfizer in 2012, bringing the product into Pfizer's consumer health portfolio In December 2018, Pfizer and GSK announced plans to merge their consumer health sectors into a new joint venture The new joint venture combines the consumer health care brands with highly complementary categories and high market share of the two companies, including GSK's comfort reach, Futalin and Billiton, Pfizer's Advil, Shancun and Caltech, and ranks first in the U.S market and second in the Chinese market in terms of OTC product share The merger was completed in 2019, with GSK owning 68% of the new entity and Pfizer owning the remaining 32% Pfizer and GSK integrate consumer health assets: GSK's 2009 financial report according to pennlive, Carlisle's factory is well-known locally When Alacer first started production at the plant, he promised to create 70 jobs in three years But now, after acquisitions, mergers and corporate restructuring, the plant will cut 260 jobs and shut down Pfizer's plant in Puerto Rico is funded by a new consumer healthcare joint venture A spokeswoman said job opportunities are expected to increase locally as production shifts Puerto Rico is an autonomous region of the United States Its main industries include pharmaceuticals, electronics, petrochemicals, food processing, textiles and clothing, etc The new joint venture's sales in 2019 were £ 9 billion ($11.7 billion), up 2%, according to corporate earnings The new company is phasing out low margin contract manufacturing In 2020, GSK also launched a two-year split plan to spin off its share of consumer healthcare business into an independent company, while "new" GSK, as a biopharmaceutical company, focuses on scientific research related to immune system, genetics and new technology to improve operational performance Reference source: GSK to close U.S consumerplant, killing 260 jobs